Rattus norvegicus angiopoietin 2, mRNA (cDNA clone MGC:187710 IMAGE:90 - Nucleotide

Run BLAST
Find regions of similarity between this sequence and other sequences using BLAST.
Pick Primers
Design and test primers for this sequence using Primer-BLAST.

siRNA knockdown of angiopoietin 2 significantly reduces neovascularization in diabetic rats. [J Drug Target. 2022]
siRNA knockdown of angiopoietin 2 significantly reduces neovascularization in diabetic rats.
Cabrera-Becerra SE, Vera-Juárez G, García-Rubio VG, Ocampo-Ortega SA, Blancas-Napoles CM, Aguilera-Méndez A, Romero-Nava R, Huang F, Hong E, Villafaña S. J Drug Target. 2022 Jul; 30(6):673-686. Epub 2022 Mar 22.
Short-term angiotensin II treatment regulates cardiac nanomechanics via microtubule modifications. [Nanoscale. 2020]
Short-term angiotensin II treatment regulates cardiac nanomechanics via microtubule modifications.
Swiatlowska P, Sanchez-Alonso JL, Mansfield C, Scaini D, Korchev Y, Novak P, Gorelik J. Nanoscale. 2020 Aug 6; 12(30):16315-16329.
Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients. [Angiogenesis. 2020]
Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients.
Smadja DM, Guerin CL, Chocron R, Yatim N, Boussier J, Gendron N, Khider L, Hadjadj J, Goudot G, Debuc B, et al. Angiogenesis. 2020 Nov; 23(4):611-620. Epub 2020 May 27.

Your browsing activity is empty.

Activity recording is turned off.

Nucleotide